InphA under new management

On 1 October 2021, Dr Tanja Pallmann took over the management of InphA GmbH. She succeeds Dr Konrad Horn as the head of the institute.
Dr Pallmann holds a doctorate in pharmacy and has many years of experience in the pharmaceutical industry. She was responsible for
national and international functions in quality management, quality control and as a qualified person.
Her extensive expertise is an ideal basis to continue the successful path of InphA and to position the Institute for the future.